Estropipate
From Wikipedia, the free encyclopedia
| This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (June 2009) |
"Ogen" redirects here. For the character in the Japanese anime, see Ogen (Basilisk).
| Systematic (IUPAC) name | |
|---|---|
| [(8R,9S,13S,14S)-13-Methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate; piperazine | |
| Clinical data | |
| AHFS/Drugs.com | monograph |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 7280-37-7 |
| ATC code | None |
| PubChem | CID 5284555 |
| DrugBank | DB04574 |
| ChemSpider | 4447610 |
| UNII | SVI38UY019 |
| KEGG | D00948 |
| ChEMBL | CHEMBL1200980 |
| Chemical data | |
| Formula | C22H32N2O5S |
| Mol. mass | 436.56 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Estropipate is a form of estrogen sold under the brand names Ogen and Ortho-Est. It is a salt of estrone sulfate and piperazine.
[edit] Uses
Estropipate is used to:
- Alleviate symptoms of menopause as hormone replacement therapy
- Treat some types of infertility
- Treat some conditions leading to underdevelopment of female sexual characteristics
- Treat vaginal atrophy
- Treat some types of breast cancer (particularly in men and postmenopausal women)
- Treat prostate cancer
- Prevent osteoporosis
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |